Context Therapeutics (CNTX) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MIRA Pharmaceuticals (MIRA) has outperformed Context Therapeutics (CNTX) over the past year, losing 44.4% versus a loss of 78.3%. MIRA Pharmaceuticals is the larger company by market cap ($31.3 million vs $27.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTX | MIRA |
|---|---|---|
| Share price | $0.3042 | $0.7455 |
| Market cap | $27.95M | $31.33M |
| 1-day change | +1.74% | +6.05% |
| YTD return | -79.31% | -50.63% |
| 1-year return | -78.27% | -44.37% |
| EPS (TTM) | $-0.49 | $-1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $2.45 |
| 52-week low | $0.295 | $0.60 |
| Distance from 52-week high | -91.60% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +1224.79% | +369.48% |
| Average volume | 1.62M | 585.75K |
| Shares outstanding | 91.88M | 42.02M |
| Employees | 15 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MIRA has outperformed CNTX by 33.9 percentage points over the past year.
About Context Therapeutics
CNTX stock →Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
CNTX vs MIRA FAQ
Which is bigger, Context Therapeutics or MIRA Pharmaceuticals?
MIRA Pharmaceuticals (MIRA) is larger, with a market capitalization of $31.33M compared with $27.95M for Context Therapeutics (CNTX).
Which stock has performed better over the past year, CNTX or MIRA?
MIRA returned -44.37% over the past 12 months, compared with -78.27% for CNTX (price return, excluding dividends). Past performance does not predict future results.
Are Context Therapeutics and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.